Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Tyrer

Showing results (271-280 of 368) with videos related to

Pageof 37
Sort By:
Neuroreport|June 27, 1994
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.
Archives of General Psychiatry|July 1, 1989
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reportsI M Marks, A De Albuquerque, J Cottraux, et al.
European Journal of Pharmacology|December 12, 1996
L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assaysG R Seabrook, S L Shepheard, D J Williamson, et al.
Psychological Medicine|August 1, 2008
Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trialK M Davidson, P Tyrer, P Tata, et al.
Archives of Dermatology|February 23, 2005
Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndromeN Afrina Alam, Ella Barclay, Andrew J Rowan, et al.
Health Technology Assessment (Winchester, England)|September 5, 2001
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient careM Marshall, R Crowther, A Almaraz-Serrano, et al.
Communications in Psychopharmacology|January 1, 1978
Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?M Sandler, C R Ruthven, B L Goodwin, et al.
Neurology|June 9, 2004
Influence of the amyloid precursor protein locus on dementia in Down syndromeM Margallo-Lana, C M Morris, A M Gibson, et al.
Biological Psychiatry|February 15, 1997
Gastrointestinal absorption of aluminum is increased in Down's syndromeP B Moore, J A Edwardson, I N Ferrier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2003
Comorbidity of substance misuse and mental illness in community mental health and substance misuse servicesT Weaver, P Madden, V Charles, et al.
Pageof 37

Showing results (271-280 of 368) with videos related to

Sort By:
Pageof 37
Neuroreport|June 27, 1994
Gender differences in the phenotypic expression of Alzheimer's disease in Down's syndrome (trisomy 21)R Raghavan, C Khin-Nu, A G Brown, et al.
Archives of General Psychiatry|July 1, 1989
The 'efficacy' of alprazolam in panic disorder and agoraphobia: a critique of recent reportsI M Marks, A De Albuquerque, J Cottraux, et al.
European Journal of Pharmacology|December 12, 1996
L-733,060, a novel tachykinin NK1 receptor antagonist; effects in [Ca2+]i mobilisation, cardiovascular and dural extravasation assaysG R Seabrook, S L Shepheard, D J Williamson, et al.
Psychological Medicine|August 1, 2008
Cognitive behaviour therapy for violent men with antisocial personality disorder in the community: an exploratory randomized controlled trialK M Davidson, P Tyrer, P Tata, et al.
Archives of Dermatology|February 23, 2005
Clinical features of multiple cutaneous and uterine leiomyomatosis: an underdiagnosed tumor syndromeN Afrina Alam, Ella Barclay, Andrew J Rowan, et al.
Health Technology Assessment (Winchester, England)|September 5, 2001
Systematic reviews of the effectiveness of day care for people with severe mental disorders: (1) acute day hospital versus admission; (2) vocational rehabilitation; (3) day hospital versus outpatient careM Marshall, R Crowther, A Almaraz-Serrano, et al.
Communications in Psychopharmacology|January 1, 1978
Raised cerebrospinal fluid phenylacetic acid concentration: preliminary support for the phenylethylamine hypothesis of schizophrenia?M Sandler, C R Ruthven, B L Goodwin, et al.
Neurology|June 9, 2004
Influence of the amyloid precursor protein locus on dementia in Down syndromeM Margallo-Lana, C M Morris, A M Gibson, et al.
Biological Psychiatry|February 15, 1997
Gastrointestinal absorption of aluminum is increased in Down's syndromeP B Moore, J A Edwardson, I N Ferrier, et al.
The British Journal of Psychiatry : the Journal of Mental Science|October 2, 2003
Comorbidity of substance misuse and mental illness in community mental health and substance misuse servicesT Weaver, P Madden, V Charles, et al.
Pageof 37